The Biotechnology Industry Organization (BIO) and the Colorado BioScience Association (CBSA) commend Colorado Governor John Hickenlooper for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines. Governor Hickenlooper signed the legislation into law on April 3rd. The Colorado House of Representatives passed Senate Bill 71 in March with a vote… Keep reading →
Association of Clinical Research Organizations (ACRO) Executive Director Doug Peddicord today issued the following statement on the Resolution (H.Res.733) introduced by Representative Scott Peters (D-CA) in the House of Representatives to designate September as Clinical Research Innovation Month in America: Representative Scott Peters (D-CA) Champions Clinical Research Innovation Month “ACRO members take pride in the… Keep reading →
Health spending in July 2014 grew 4.3% over July 2013, bringing the year-to-date increase to 4.4%. This is well above the 3.6% growth rate estimated for 2013 by the Centers for Medicare & Medicaid Services and, with further acceleration expected in the final two quarters, puts 2014 on track to be the first year since… Keep reading →
The Biotechnology Industry Organization (BIO) and the Massachusetts Biotechnology Council (MassBio) commend Massachusetts Governor Deval Patrick for signing legislation yesterday designed to create a pathway for the substitution of interchangeable biologic medicines. The policies outlined in House Bill 3734 align with all five of BIO’s principles on biologic substitution. BIO and MassBio commend Massachusetts’s Senate… Keep reading →
The Consumer Healthcare Products Association (CHPA) applauds U.S. Reps. Bill Johnson (R–Ohio) and Bruce Braley (D–Iowa) for introducing bipartisan legislation aimed at preventing teen abuse of over-the-counter (OTC) cough medicines by prohibiting the sale of OTC cough medicines containing dextromethorphan (DXM) to anyone under the age of 18. The Preventing Abuse of Cough Treatments (PACT)… Keep reading →
Today, the Biotechnology Industry Organization (BIO) applauds the Senate for approving H.R. 3204, the Drug Quality and Security Act, which will create a single, uniform and national solution to safeguard the nation’s pharmaceutical supply chain against criminal counterfeiting. The bill, which passed the House of Representatives on September 28th, now will be sent to President… Keep reading →
The National Committee for Quality Assurance (NCQA) will release its analysis of the latest quality results in its State of Health Care Quality Report 2013. Findings include: Overuse of antibiotics still a problem In findings that echo and corroborate recent CDC warnings about overuse of antibiotics leading to antibiotic resistance, we see no progress on… Keep reading →